FDA extends Tarceva review on new data; Chantix patients sue Pfizer over alleged effects;

> OSI Pharmaceuticals said FDA extended a review of its lung cancer drug Tarceva by 90 days after it submitted additional data in support of broader use. Report

> Three personal injury lawsuits were filed against Pfizer claiming its smoking-cessation drug Chantix caused attempted suicides or death. Report

> Bayer denied any involvement in fixing the price of its Levitra erectile dysfunction medicine and said it will appeal a ruling by the Swiss competition commission. Report

> Abbott Laboratories said it remains committed to completing the acquisition of Wockhardt's nutrition business, despite opposition to the deal from the Indian pharmaceutical company's overseas lender. Report

> India's Ranbaxy Laboratories agree to buy product rights and manufacturing facilities from Bangalore-based vaccine firm Biovel Lifesciences. Report

> The Fund for Philadelphia said it has received a $135,000 grant from GlaxoSmithKline for the city's Breast Health Outreach and Counseling Program. Report

Biotech News

> With new polls in Massachusetts giving Republican Scott Brown the edge in the Senate race against Martha Coakley, a number of analysts are starting to calculate the market implications if the Democrats lose their 60-vote majority in the Senate. Report 

> One of the leading figures in India's biotech industry is predicting a $10B industry boom. Story

> Louisville, CO-based GlobeImmune has hauled in a $17.5 million Series E round, which was led by Generali Financial Holding and BSI SA. Report

> GenVec has scored a $213M licensing deal with Novartis. Article

Biotech Research News

> A Yale team says that it has concluded that mutations in different cells can conspire to cause cancer. Story

> A group of fat-producing cells possesses "dual personalities" that could lead researchers to new therapies for muscle diseases like fibrosis. " Report

> A specially designed skin graft has been used to deliver molecules needed to treat high blood pressure in mice, and scientists say the same basic approach holds the promise to treat a number of conditions in humans. Report

> A team of researchers at the acclaimed Fred Hutchinson Cancer Research Center in Seattle has developed a new technique that can be used to harvest a rich supply of stem cells from cord blood. Story

> Scientists inadvertently relied on contaminated cell lines to study new drugs for esophageal cancer, and the finding has thrown into question a number of major cancer studies. Report

> A Harvard team has determined that zebrafish offer an economical and efficient animal model to test new compounds for sleep therapy. Story

Biotech IT News

> Barcelona-based drug-maker Almirall, a long-time customer of Perceptive Informatics, has gone back to the well, selecting the DataLabs electronic data capture solution for use in upcoming trials of respiratory therapeutics. Story

> The cost and effort of in vitro drug studies may be blunted by software tools in drug metabolite safety assessments. Report

> Visual-computing solutions provider NVIDIA sees computational biology as "one of the lowest hanging fruits" that can benefit from application acceleration via graphics processing units. Report

> Best practices for edit check design have been bundled by the Society for Clinical Data Management into "Edit Check Design Principles." Story

> Talk about data volume: Third-generation sequencing technologies will make it possible to catalog the DNA of every individual in large populations. Story

> Bob Kaplan plans to use his software-innovation experience to put some pre-commercial tweaks on StudyCTMS, the regulatory-informed clinical trial management system developed by contract researcher Clinical Trials & Surveys Corp. Report

And Finally... Researchers found an altered gene that touches off anxious behavior in both humans and mice. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.